Pancreatic Epithelial IL17/IL17RA Signaling Drives B7-H4 Expression to Promote Tumorigenesis.

Saved in:
Bibliographic Details
Title: Pancreatic Epithelial IL17/IL17RA Signaling Drives B7-H4 Expression to Promote Tumorigenesis.
Authors: Castro-Pando S; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas., Howell RM; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Li L; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Mascaro M; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.; CONICET, Buenos Aires, Argentina., Faraoni EY; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Le Roux O; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Romanin D; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tahan V; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Riquelme E; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang Y; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kolls JK; Department of Medicine and Pediatrics, Tulane School of Medicine, New Orleans, Louisiana., Allison JP; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lozano G; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas., Moghaddam SJ; Department of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas., McAllister F; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Source: Cancer immunology research [Cancer Immunol Res] 2024 Sep 03; Vol. 12 (9), pp. 1170-1183.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2326-6074
DOI:10.1158/2326-6066.CIR-23-0527